infectious diseases

Texas A&M School of Public Health experts explain the effort to prevent COVID-19 from rebounding as the state reopens.

Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.

A Texas A&M researcher says results from clinical trials indicate that they could be an effective way to treat coronavirus patients who develop complications.

Texas A&M researchers, alongside the Houston Methodist Research Institute and Houston Methodist Hospital system, assessed how front-line health care workers have been affected by the pandemic.

Scientists are recruiting hundreds of medical workers to test the existing vaccine's ability to mitigate the effects of the illness. Results are expected within six months.

Texas A&M professor says covering nose and mouth in public is a simple, yet critical habit people should adopt immediately.

Staff at the A.P. Beutel Health Center continue to serve students on and off the Texas A&M campus through in-person and virtual care.

A team from the School of Public Health is using state data to refine its modeling efforts.

Although the new coronavirus is at top of mind, it’s only one of many pathogens that may be lurking throughout our homes. The Texas A&M offers a guide to cleaning household surfaces.

Researchers created an online dashboard to help local authorities make key decisions about COVID-19 hot spots and how the disease is spreading.